Author: Jody Chudley, Wealthy Retirement

After 12 years of not buying a single stock for Daily Journal’s (a company he chairs) portfolio, Berkshire Hathaway’s number two man has finally made another move.

It could rise almost 50% by the end of 2022.

Now is not the time to be an aggressive buyer of equities.

Biotech stocks have been millionaire-makers. And to make a huge difference to your wealth, you need to find only a single one.

After almost six years of underperformance these stocks are cheap again. Now is the time to be a buyer.